$7.97
+0.23(2.90%)
Mkt Cap $207M
$4.84
$13.22
52-Week Range
At a Glance
AI-generatedNeoGenomics, Inc.
Revenue breakdown: Client Direct Billing (71.9%), Commercial Insurance (15.4%), Medicare And Other Governmental (12.6%).
8-K
NeoGenomics, Inc. reported Q4 2025 consolidated revenue of $190 million, up 11% from Q4 2024, and full year 2025 revenue of $727 million, up 10% from 2024. The company issued 2026 guidance for revenue of $793-$801 million and adjusted EBITDA of $55-$57 million.$207M
Market Cap
$734M
Revenue
-$109M
Net Income
Employees2,200
Fundamentals
How The Business Makes Money
Revenue by Segment
Client Direct Billing71.9%($1.4B)
Commercial Insurance15.4%($305M)
Medicare And Other Governmental12.6%($250M)
Self Pay Services0.1%($1M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001077183
ISINUS64049M2098
CUSIP64049M209
Phone239 768 0600
Address9490 NeoGenomics Way, Fort Myers, FL, 33912, US
SEC EDGAR